Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study - Contacts and Locations

Home

Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study

This study has been terminated.

Study NCT00365443. Last updated on March 19, 2007. Information provided by Merck

Please refer to this study by its ClinicalTrials.gov identifier: NCT00365443

Locations


United States, Ohio
	Call for Information
	Cleveland, Ohio, United States, 44122

Sponsors and Collaborators

Merck

Investigators


Study Director:	Medical Monitor	Merck